Organisation: Vectura

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Marlboro moves closer to controversial deal for asthma drugmaker Vectura

Scientific organisations and health charities questioned the ethics of a tobacco company owning a maker of treatments for illnesses caused or worsened by smoking

Fri, 13 Aug, 2021

Novartis to slash 2,000 jobs as part of cost-cutting drive

NOVARTIS is slashing 2,000 jobs in Switzerland and the US to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said yesterday.

Wed, 26 Oct, 2011

Renevo makes second attempt at floatation

The improving fortunes of the UK biotech industry were highlighted today when Renovo launched its second attempt to list on the stock market.

Mon, 27 Mar, 2006

'Smoker's lung' drug wins firms multi-million pound deal

An inhaler treatment for “smoker’s lung” was today at the centre of one of the biggest-ever deals in the UK biotech sector.

Wed, 13 Apr, 2005

Inhaled drugs firm plans flotation

A biotechnology company which is developing an inhaled alternative to Viagra today announced plans to float on the London stock market.

Mon, 14 Jun, 2004